Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis

J Int Med Res. Jan-Feb 2008;36(1):204-8; author reply 208-10.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Antibodies, Blocking / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Interferon beta-1b
  • Interferon-beta / immunology*
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology
  • Neutralization Tests
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Antibodies, Blocking
  • Interferon beta-1b
  • Interferon-beta